CHG-2022-0275

New Dosage Strength for Immunovant-α. Specification Change for Immunovant-α — minor update. Impacts 1 markets and 2 variations.

Change Number
CHG-2022-0275
Type
New Dosage Strength
Product
Immunovant-α
Status
Overdue
Owner
James O'Brien
Initiated
2022-07-22
Description

Specification Change for Immunovant-α — minor update

Impacted Markets (1)
IN — India
Impacted Modules
3.2.P.34.2.13.2.P5.3.5
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved